HomeSvelte Medical Systems

Svelte Medical Systems

First-in-Man Study Using the World’s First Drug-Eluting Stent-on-a-Wire Completes 5-Year Follow-up with 0% Major Adverse Cardiac Events; No Additional Revascularizations Through 3-Years in DIRECT II Study

“Longer-term follow-up of novel coronary stents is very important, as shown by the recent findings of unexpectedly high rates of very late thrombosis in bioresorbable scaffolds. The absence of late adverse clinical events through 5 years is...